1. Home
  2. STKE vs NEPH Comparison

STKE vs NEPH Comparison

Compare STKE & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STKE

Sol Strategies Inc.

HOLD

Current Price

$1.03

Market Cap

38.3M

Sector

N/A

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.64

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKE
NEPH
Founded
2002
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
40.1M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
STKE
NEPH
Price
$1.03
$4.64
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
125.3K
15.3K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.12
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
$552.94
$11.58
P/E Ratio
N/A
$39.08
Revenue Growth
N/A
32.67
52 Week Low
$0.85
$2.66
52 Week High
$7.75
$6.42

Technical Indicators

Market Signals
Indicator
STKE
NEPH
Relative Strength Index (RSI) 41.15 68.13
Support Level $0.96 $4.44
Resistance Level $1.11 $4.69
Average True Range (ATR) 0.06 0.34
MACD 0.01 0.11
Stochastic Oscillator 42.35 85.88

Price Performance

Historical Comparison
STKE
NEPH

About STKE Sol Strategies Inc.

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: